Michael A. Hoer
Known title: DirectorCIK: 0001743755
Michael A. Hoer's purchase track record
How the stock did after each of Michael A. Hoer's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since November 8, 2022
Stock higher 6 months later
0%
3 months: 40%
Median 6-month return
-19.4%
3 months: -21.4%
Beat the S&P 500
0%
median -27.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/7/2023 | MED | $3K | -21.8% | -63.0% | +18.5% |
| 8/8/2023 | MED | $3K | -21.4% | -38.5% | +10.1% |
| 5/9/2023 | MED | $1K | +4.1% | -18.1% | +6.3% |
| 2/7/2023 | MED | $1K | -22.6% | -19.4% | +8.1% |
| 11/8/2022 | MED | $1K | +6.6% | -17.5% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MED | ▲ Buy | Grant | 11,168 | $0 | 6/25/2025 | View on chart |
| MED | ▲ Buy | Grant | 6,596 | $0 | 6/20/2024 | View on chart |
| MED | ▲ Buy | Open Market | 50 | $3K | 11/7/2023 | View on chart |
| MED | ▲ Buy | Open Market | 38 | $3K | 8/8/2023 | View on chart |
| MED | ▲ Buy | Grant | 3,118 | $0 | 6/15/2023 | View on chart |
| MED | ▲ Buy | Open Market | 13 | $1K | 5/9/2023 | View on chart |
| MED | ▲ Buy | Open Market | 10 | $1K | 2/7/2023 | View on chart |
| MED | ▲ Buy | Open Market | 10 | $1K | 11/8/2022 | View on chart |
| MED | ▲ Buy | Grant | 8 | $1K | 8/8/2022 | View on chart |
| MED | ▲ Buy | Grant | 1,350 | $0 | 6/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
No new news for MED in the past week
There are no recent news items specifically about Medifast Inc. in the last seven days. The only recent headlines are about Hormel Foods and Boston Beer, which do not involve Medifast. Therefore, no new developments have been reported for the company itself.
No new news for MED in the past week. There are no recent news items specifically about Medifast Inc. in the last seven days. The only recent headlines are about Hormel Foods and Boston Beer, which do not involve Medifast. Therefore, no new developments have been reported for the company itself.